Related references
Note: Only part of the references are listed.High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
Jonas W. Brinck et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization
Mi-Hye Lee et al.
JOURNAL OF LIPID RESEARCH (2017)
The role of sphingolipid signalling in diabetes-associated pathologies
Mei Li Ng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Overexpression of sphingosine-1-phosphate lyase protects insulin-secreting cells against cytokine toxicity
Claudine Hahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection
Jonas W. Brinck et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Apolipoprotein A-I interactions with insulin secretion and production
Kerry-Anne Rye et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
Dual Actions of Apolipoprotein A-I on Glucose-Stimulated Insulin Secretion and Insulin-Independent Peripheral Tissue Glucose Uptake Lead to Increased Heart and Skeletal Muscle Glucose Disposal
Joan Domingo-Espin et al.
DIABETES (2016)
Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2
Lukasz Japtok et al.
FASEB JOURNAL (2015)
Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content Correction by Sphingosine-1-Phosphate-Loading
Katherine Sattler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
HDL and glucose metabolism: current evidence and therapeutic potential
Andrew L. Siebel et al.
FRONTIERS IN PHARMACOLOGY (2015)
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications
Bodo Levkau
FRONTIERS IN PHARMACOLOGY (2015)
Apolipoprotein A-I Increases Insulin Secretion and Production From Pancreatic β-Cells via a G-Protein-cAMP-PKA-FoxO1-Dependent Mechanism
Blake J. Cochran et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Regulation of calcium in pancreatic α- and β-cells in health and disease
Patrik Rorsman et al.
CELL CALCIUM (2012)
HDLs Protect Pancreatic β-Cells Against ER Stress by Restoring Protein Folding and Trafficking
Jannick Petremand et al.
DIABETES (2012)
Sphingosine 1-Phosphate (S1P) Regulates Glucose-stimulated Insulin Secretion in Pancreatic Beta Cells
Jamie Cantrell Stanford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Pax6 Is Crucial for β-Cell Function, Insulin Biosynthesis, and Glucose-Induced Insulin Secretion
Yvan Gosmain et al.
MOLECULAR ENDOCRINOLOGY (2012)
The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells
Jean-Claude Henquin
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion
Michelle A. Fryirs et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Pax6 Controls the Expression of Critical Genes Involved in Pancreatic α Cell Differentiation and Function
Yvan Gosmain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection
Katherine Sattler et al.
CARDIOVASCULAR RESEARCH (2009)
High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
Brian G. Drew et al.
CIRCULATION (2009)
Low- and High-Density Lipoproteins Modulate Function, Apoptosis, and Proliferation of Primary Human and Murine Pancreatic β-Cells
Sabine Ruetti et al.
ENDOCRINOLOGY (2009)
Involvement of 4E-BP1 in the Protection Induced by HDLs on Pancreatic β-Cells
Jannick Petremand et al.
MOLECULAR ENDOCRINOLOGY (2009)
Beyond high-density lipoprotein cholesterol levels - Evaluating high-density lipoprotein function as influenced by novel therapeutic approaches
Emil M. deGoma et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
Insulin-secreting β-cell dysfunction induced by human lipoproteins
ME Roehrich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sphingosine 1-phosphate stimulates insulin secretion in HIT-T 15 cells and mouse islets
H Shimizu et al.
ENDOCRINE JOURNAL (2000)
Share Paper
